EUVIMEDEUVIMED entdecken
Klinische Studie

Is there a correlation between TMAO plasma levels and archaea in the gut of patients undergoing hemodialysis?

Julie Ann Kemp, Júnia Schultz, Fluvio Modolon, Marcelo Ribeiro-Alves, Alexandre S Rosado, Denise Mafra

International Urology and Nephrology · 2024

DOI: 10.1007/s11255-024-04273-5 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Julie Ann Kemp und 5 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduate Program in Nutrition Sciences, Federal Fluminense University, Niterói, Rio de Janeiro, Brazil. kempjulie@gmail.com. Hauptthemen laut MEDLINE: Archaea, Gastrointestinal Microbiome, Methylamines, Renal Dialysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: King Abdullah University of Science and Technology, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Patients with chronic kidney disease (CKD) present high plasma levels of trimethylamine N-oxide (TMAO), a uremic toxin produced by gut microbiota associated with atherogenesis. Experimental studies have shown that certain methanogenic archaea members use trimethylamine (TMA), the TMAO precursor in the human gut, to produce methane, suggesting a potential strategy to reduce TMAO levels in patients with CKD. Hence, this study aimed to evaluate the association of Archaea in the gut microbiota and TMAO plasma levels in patients with CKD undergoing hemodialysis. METHODS: Twenty-five patients were enrolled in the study (15 women, 53 (18) years, BMI, 25.8 (6.75) kg/m2). TMAO plasma levels were evaluated using the HPLC-EM/EM method. Fecal DNA was extracted using a commercial kit. Subsequently, we sequenced the V4 region of the 16S rRNA gene to characterize the microbial composition. NCT04600258 was retrospectively registered in September 2022. RESULTS: According to the reference values in the European Uremic Toxins Work Group (EUTox) database, the patients exhibited high TMAO plasma levels, as expected. The most abundant Archaea members were assigned to the Euryarchaeota phylum, the Methanobacteriaceae family, and the genus Methanobrevibacter. A significant negative correlation between TMAO and Methanobrevibacter was observed. CONCLUSIONS: To our knowledge, this study represents the first investigation into the correlation between TMAO levels and the prevalence of Archaea in patients with CKD. Our findings support the archaebiotic hypothesis, suggesting that specific members of the archaea community could play a crucial role in reducing TMA production in the human gut, potentially decreasing TMAO synthesis in CKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArchaeaGastrointestinal MicrobiomeMethylaminesRenal DialysisRenal Insufficiency, ChronicAdultAgedFemaleHumansMaleMiddle AgedRetrospective Studies

Stichwörter der Autor:innen

ArchaeaChronic kidney diseaseHemodialysisTrimethylamine N-oxide

Substanzen

Methylaminestrimethyloxamine

Autor:innen und Institutionen

  • Post-Graduate Program in Nutrition Sciences, Federal Fluminense University, Niterói, Rio de Janeiro, Brazil. kempjulie@gmail.com.
  • Biological and Environmental Science and Engineering (BESE), Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
  • Oceanographic Institute, University of Sao Paulo, São Paulo, SP, Brazil.
  • HIV/AIDS Clinical Research Center, National Institute of Infectology Evandro Chagas (INI/Fiocruz), Rio de Janeiro, RJ, Brazil.
  • Post-Graduate Program in Nutrition Sciences, Federal Fluminense University, Niterói, Rio de Janeiro, Brazil.
  • Graduate Program in Biological Sciences-Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

Förderung

  • King Abdullah University of Science and Technology
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Kemp, J. A., Schultz, J., Modolon, F., Ribeiro-Alves, M., Rosado, A. S., & Mafra, D. (2024). Is there a correlation between TMAO plasma levels and archaea in the gut of patients undergoing hemodialysis?. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04273-5

Vancouver

Kemp JA, Schultz J, Modolon F, Ribeiro-Alves M, Rosado AS, Mafra D. Is there a correlation between TMAO plasma levels and archaea in the gut of patients undergoing hemodialysis?. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04273-5

BibTeX
@article{Kemp2024,
  author = {Kemp, Julie Ann and Schultz, Júnia and Modolon, Fluvio and Ribeiro-Alves, Marcelo and Rosado, Alexandre S and Mafra, Denise},
  title = {Is there a correlation between TMAO plasma levels and archaea in the gut of patients undergoing hemodialysis?},
  journal = {International Urology and Nephrology},
  year = {2024},
  doi = {10.1007/s11255-024-04273-5}
}
Kostenlos starten →